Understanding How a Key Receptor Controls Body Processes
Multifaceted Regulation of Mineralocorticoid Receptor Transcriptional Activities
This project aims to understand how a specific protein, the mineralocorticoid receptor (MR), works in the body, which could help in developing better treatments for heart and kidney diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11166583 on NIH RePORTER |
What this research studies
This project looks closely at how a protein called the mineralocorticoid receptor, or MR, functions within our cells. MR plays a vital role in managing fluid and salt balance, and it's also found in important areas like the heart, blood vessels, brain, and fat tissue. When MR becomes too active, it can lead to problems like inflammation and damage in these tissues, contributing to heart and kidney conditions. By understanding the detailed steps of how MR works, we hope to find new ways to improve existing medicines or create entirely new ones. This deeper knowledge could lead to more effective treatments for people with cardiovascular and kidney diseases.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation, but future clinical applications could benefit individuals with cardiovascular and renal diseases linked to mineralocorticoid receptor overactivity.
Not a fit: Patients whose conditions are not related to the mineralocorticoid receptor's activity would likely not see direct benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to a better understanding of how the mineralocorticoid receptor contributes to disease, potentially guiding the development of more effective treatments for cardiovascular and renal conditions.
How similar studies have performed: While MR antagonists are already used in therapy, this project aims for a deeper molecular understanding of MR activity, which is a novel approach to improving future drug development.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Liu, Xu — Emory University
- Study coordinator: Liu, Xu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.